Literature DB >> 12086970

Maturity-onset diabetes of the young caused by a balanced translocation where the 20q12 break point results in disruption upstream of the coding region of hepatocyte nuclear factor-4alpha (HNF4A) gene.

Anna L Gloyn1, Sian Ellard, Maggie Shepherd, Rodney T Howell, Elizabeth M Parry, Andrew Jefferson, Elaine R Levy, Andrew T Hattersley.   

Abstract

Monogenic human disorders have been used as paradigms for complex genetic disease and as tools for establishing important insights into mechanisms of gene regulation and transcriptional control. Maturity-onset diabetes of the young (MODY) is a monogenic dominantly inherited form of diabetes that is characterized by defective insulin secretion from the pancreatic beta-cells. A wide variety of mutation types in five different genes have been identified that result in this condition. There have been no reports of a chromosome deletion or translocation resulting in MODY. We report a pedigree where MODY cosegregates with a balanced translocation [karyotype 46, XX t(3;20) (p21.2;q12)]. The chromosome 20 break point, 20q12, is within the region of one of the known MODY genes, hepatocyte nuclear factor-4alpha (HNF4A). Fluorescence in situ hybridization analysis demonstrated that the break point does not disrupt the coding region of this gene, but it lies at least 6 kb upstream of the conventional promoter (P1). We propose that this mutation disrupts the spatial relationship between the recently described alternate distal pancreatic promoter (P2) and HNF4A. This is the first case of MODY due to a balanced translocation, and it provides evidence to confirm the crucial role of an upstream regulator of HNF4A gene expression in the beta-cell.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12086970     DOI: 10.2337/diabetes.51.7.2329

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

Review 1.  Transcriptional networks controlling pancreatic development and beta cell function.

Authors:  J M Servitja; J Ferrer
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

2.  Characterization of complex chromosomal rearrangements by targeted capture and next-generation sequencing.

Authors:  Nara L M Sobreira; Veena Gnanakkan; Michael Walsh; Beth Marosy; Elizabeth Wohler; George Thomas; Julie E Hoover-Fong; Ada Hamosh; Sarah J Wheelan; David Valle
Journal:  Genome Res       Date:  2011-09-02       Impact factor: 9.043

3.  Clinical utility gene card for: Maturity-onset diabetes of the young.

Authors:  Kevin Colclough; Cécile Saint-Martin; José Timsit; Sian Ellard; Christine Bellanné-Chantelot
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

4.  A balanced translocation truncates Neurotrimin in a family with intracranial and thoracic aortic aneurysm.

Authors:  Tiia M Luukkonen; Minna Pöyhönen; Aarno Palotie; Pekka Ellonen; Sonja Lagström; Joseph H Lee; Joseph D Terwilliger; Riitta Salonen; Teppo Varilo
Journal:  J Med Genet       Date:  2012-10       Impact factor: 6.318

5.  Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection.

Authors:  E R Pearson; S Pruhova; C J Tack; A Johansen; H A J Castleden; P J Lumb; A S Wierzbicki; P M Clark; J Lebl; O Pedersen; S Ellard; T Hansen; A T Hattersley
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

6.  MODY-like diabetes associated with an apparently balanced translocation: possible involvement of MPP7 gene and cell polarity in the pathogenesis of diabetes.

Authors:  Elizabeth J Bhoj; Stefano Romeo; Marco G Baroni; Guy Bartov; Roger A Schultz; Andrew R Zinn
Journal:  Mol Cytogenet       Date:  2009-02-13       Impact factor: 2.009

7.  The IHPK1 gene is disrupted at the 3p21.31 breakpoint of t(3;9) in a family with type 2 diabetes mellitus.

Authors:  Junichi Kamimura; Keiko Wakui; Hiroko Kadowaki; Yukio Watanabe; Kazuaki Miyake; Naoki Harada; Michiyo Sakamoto; Akira Kinoshita; Koh-Ichiro Yoshiura; Tohru Ohta; Tatsuya Kishino; Mutsuo Ishikawa; Masato Kasuga; Yoshimitsu Fukushima; Norio Niikawa; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2004-06-18       Impact factor: 3.172

8.  Mapping translocation breakpoints by next-generation sequencing.

Authors:  Wei Chen; Vera Kalscheuer; Andreas Tzschach; Corinna Menzel; Reinhard Ullmann; Marcel Holger Schulz; Fikret Erdogan; Na Li; Zofia Kijas; Ger Arkesteijn; Isidora Lopez Pajares; Margret Goetz-Sothmann; Uwe Heinrich; Imma Rost; Andreas Dufke; Ute Grasshoff; Birgitta Glaeser; Martin Vingron; H Hilger Ropers
Journal:  Genome Res       Date:  2008-03-07       Impact factor: 9.043

Review 9.  Therapeutic Potential of HNF4α in End-stage Liver Disease.

Authors:  Ricardo Diaz-Aragon; Michael C Coard; Sriram Amirneni; Lanuza Faccioli; Nils Haep; Michelle R Malizio; Takashi Motomura; Zehra N Kocas-Kilicarslan; Alina Ostrowska; Rodrigo M Florentino; Carla Frau
Journal:  Organogenesis       Date:  2021-10-02       Impact factor: 2.316

10.  Severe insulin resistance and intrauterine growth deficiency associated with haploinsufficiency for INSR and CHN2: new insights into synergistic pathways involved in growth and metabolism.

Authors:  Sara G I Suliman; Juraj Stanik; Laura J McCulloch; Natalie Wilson; Emma L Edghill; Nadezda Misovicova; Daniela Gasperikova; Vilja Sandrikova; Katherine S Elliott; Lubomir Barak; Sian Ellard; Emanuela V Volpi; Iwar Klimes; Anna L Gloyn
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.